The Effects of Aspirin on Megakaryocyte Prostaglandin Production
- 1 January 1980
- journal article
- research article
- Published by Frontiers Media SA in Experimental Biology and Medicine
- Vol. 163 (1) , 24-29
- https://doi.org/10.3181/00379727-163-40716
Abstract
Aspirin inhibits the enzyme cyclooxygenase in platelets by irreversibly acetylating it. Since platelets are derived from the fragmentation of megakaryocyte cytoplasm and contain similar organelles and enzymes, the inhibitory effect of aspirin on the prostaglandin synthesis of isolated rat megakaryocytes was studied. Megakaryocytes were isolated from rat bone marrow using cellular velocity sedimentation in an isokinetic Ficoll gradient. The isolated megakaryocytes were capable of significant prostaglandin E synthesis as measured by radioimmunoassay when exposed to N-ethylmaleimide (NEM). Aspirin pretreatment in vivo abolished the ability of rat megakaryocytes to synthesize prostaglandin E. Aspirin can also acetylate irreversibly the megakaryocyte cyclooxygenase enzyme and this defect may be carried over to the newly formed platelets. These results may significantly influence the dose schedules of antiplatelet drugs currently being used in clinical trials.This publication has 5 references indexed in Scilit:
- Lipoxygenation activity of purified prostaglandin-forming cyclooxygenaseBiochemistry, 1978
- Acetylation of prostaglandin synthetase by aspirin. Purification and properties of the acetylated protein from sheep vesicular glandBiochemistry, 1977
- Effect of aspirin on prostaglandin synthesis by human plateletsProstaglandins, 1976
- Persistence of thromboxane A2-like material and platelet release-inducing activity in plasma.Journal of Clinical Investigation, 1976
- Kinetics of thrombopoiesisJournal of Clinical Investigation, 1968